Biogen reported $821M in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -26415000 7.15M
Amgen AMGN:US USD 2.54B 364M
Biogen BIIB:US USD 821M 53.8M
Biomarin Pharmaceutical BMRN:US USD -1904000 36.75M
Bluebird Bio BLUE:US USD -76513000 16.99M
Esperion Therapeutics ESPR:US USD -55117000 11.21M
Intercept Pharmaceuticals ICPT:US USD -104087000 83.77M
Intra Cellular Therapies ITCI:US USD -53507000 33.1M
Marinus Pharmaceuticals MRNS:US USD 75.04M 114.48M
Moderna Inc MRNA:US USD 1.22B 1.26B
Neurocrine Biosciences NBIX:US USD 97.9M 121.2M
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 7.38B 3.3B
Ptc Therapeutics PTCT:US USD -127208000 21.49M
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
Sangamo Biosciences SGMO:US USD -53125000 10.03M
Sanofi SAN:FP EUR 4.43B 1.77B
Sarepta Therapeutics SRPT:US USD -256418000 28.32M
Seattle Genetics SGEN:US USD -188527000 53.81M
Teva Pharmaceutical TEVA:IT USD 768M 1.93B
Ultragenyx Pharmaceutical RARE:US USD -238819000 80.96M
United Therapeutics UTHR:US USD 312.5M 161.9M
YTE INCY:US USD 178.22M 131.36M